Huff James Warren

Chief Executive Officer at REATA PHARMACEUTICALS INC

Sold, on record
$26.2M
Dollars the filings state
Form 4 sales
3
Latest Mar 2, 2023
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale REATA PHARMACEUTICALS INCUnusual
    Sep 27 2019

    Sold 63,000 shares at $86.61 ($5.5M)

    Huff James Warren, Chief Executive Officer

    Sold 40.1% of holdings ($13.6M position)94,157 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale REATA PHARMACEUTICALS INCUnusual
    Nov 10 +410 days

    Sold 81,657 shares at $175.01 ($14.3M)

    Huff James Warren, Chief Executive Officer

    Sold 100% of holdings ($14.3M position)0 shares leftFiling

  3. 3 Form 4 sale REATA PHARMACEUTICALS INCUnusual
    Mar 2 +842 days

    Sold 75,000 shares at $85.46 ($6.4M)

    Huff James Warren, Chief Executive Officer

    Sold 67.5% of holdings ($9.5M position)36,158 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Huff James Warren
Source
Mar 2, 2023REATA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale75,000$6.4M67.5%UnusualSEC
Nov 10, 2020REATA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale81,657$14.3M100.0%UnusualSEC
Sep 27, 2019REATA PHARMACEUTICALS INCChief Executive OfficerForm 4 sale63,000$5.5M40.1%UnusualSEC